Launch the Developer Dashboard
Site Management and Clinical Trials Logistics

​Site management and clinical trials logistics issues are diverse and addressing each issue is likely to involve a varied group of individuals with specific expertise. Network Leadership, DAIDS Leadership, and HANC work closely with the Office of Clinical Site Oversight (OCSO) and Office of Policy in Clinical Research Operations (OPCRO) at DAIDS to identify site concerns and identify appropriate individuals to engage in ad-hoc working groups dedicated towards addressing specified issues.​

In 2010, HANC formed an on-going cross-network Site Coordinators working group to address issues of common concern and harmonize policies and procedures regarding site-level operations.

The Financial Disclosure Working Group develops and maintains cross-network financial disclosure guidelines.​​​​

Communication Process to Address Site Level Issues

In order to address such a wide variety of issues, HANC has set-up processes in place to facilitate communication and connect the right individuals.

Do you have an issue or concern you would like to see addressed? Contact us!

More information

​Financial Disclosure SOP

HANC-facilitated Financial Disclosure Working Group is pleased to announce version 1.0 of the “NIAID (DAIDS)-supported and/or Sponsored HIV/AIDS Clinical Trials Networks Financial Disclosure and Conflict of Interest Guidelines”.

The guidelines are intended to identify significant financial interests of network-affiliated researchers and avoid conflicts of interest, or the appearance of such conflicts, in activities of the networks.   Network Leaders approved the guidelines on the April 2010 Network Leaders call and the document has been adopted as standard operating procedure for all networks effective 15 April 2010.

View the Financial Disclosure SOP

Clinical Research Sites

Wondering where all 700+ DAIDS Clinical Trials Networks CRS are located throughout the world?

More information

​NIH FDCOI Guidance

The National Institutes of Health provides financial disclosure guidance for investigators.

More information

​FDA FDCOI Guidance

The Food and Drug Administration provides financial disclosure guidance for investigators.

More information

Digg Delicious Facebook Newsvine Reddit StumbleUpon Twitter Email Link

share:

SiteMap

sitemap:

© HIV/AIDS Network Coordination